26 results
8-K
AKBA
Akebia Therapeutics Inc.
8 Jan 24
Results of Operations and Financial Condition
8:02am
on Form 8-K, including Exhibit 99.1 hereto, the Company is not making an admission as to the materiality of any information herein. The information
8-K
AKBA
Akebia Therapeutics Inc.
7 Jun 23
Regulation FD Disclosure
7:31am
of this Current Report on Form 8-K, including Exhibit 99.1 hereto, the Company is not making an admission as to the materiality of any information herein
POSASR
EX-5.1
AKBA
Akebia Therapeutics Inc.
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:12pm
to contracts, including, without limitation, requirements of materiality, good faith, reasonableness and fair dealing, (iii) general equitable principles
8-K
ocmzc
9 Sep 21
Regulation FD Disclosure
6:13am
S-3ASR
EX-5.1
7nsdr0ncm glr4
25 Feb 21
Automatic shelf registration
5:21pm
8-K
ub0n9oftrx
12 Jan 21
Regulation FD Disclosure
7:06am
8-K
EX-1.1
srcfcgze2r2xo5
12 Nov 19
Entry into a Material Definitive Agreement
5:20pm
8-K
fbqwivp 8wj
4 Jun 19
Regulation FD Disclosure
7:00am
8-K
l83k2t4cpk10h
7 Jan 19
Regulation FD Disclosure
7:53am
8-K
afq7q6ewcqynb
13 Dec 18
Entry into a Material Definitive Agreement
7:16am
424B3
89x1po s2ob3h
30 Oct 18
Prospectus supplement
5:23pm
S-4/A
nj8e97nw ctu2e9r
25 Oct 18
Registration of securities issued in business combination transactions (amended)
5:18pm
S-4
ydq6p iq8x
1 Oct 18
Registration of securities issued in business combination transactions
12:00am